| [1] |
Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J]. Cell, 1993, 75(5):843-854.
|
| [2] |
Mitchell PS, Parkin RK, Kroh EM, et al.Circulating microRNAs as stable blood-based markers for cancer detection[J]. Proc Natl Acad Sci USA, 2008, 105(30):10513-10518.
|
| [3] |
Patel RS, Jakymiw A, Yao B, et al. High resolution of microRNA signatures in human whole saliva[J]. Arch Oral Biol, 2011, 56(12):1506-1513.
|
| [4] |
Wang G, Chan ES, Kwan BC, et al. Expression of microRNAs in the urine of patients with bladder cancer[J]. Clin Genitourin Cancer, 2012, 10(2):106-113.
|
| [5] |
Zhang B, Pan X, Cobb GP, et al. microRNAs as oncogenes and tumor suppressors[J]. Dev Biol, 2007, 302(1):1-12.
|
| [6] |
Chung YW, Bae HS, Song JY, et al. Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patients[J]. Int J Gynecol Cancer, 2013, 23(4):673-679.
|
| [7] |
师婕，张林燕．微小RNA-27a在子宫颈鳞癌患者血清和组织中的表达及意义[J]．中国妇产科临床杂志，2014，15(2):172-174.
|
| [8] |
Li J, Smyth P, Flavin R, et al. Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells[J]. BMC Biotechnol, 2007, 7:36.
|
| [9] |
Lee YS, Dutta A. MicroRNAs in cancer[J]. Annu Rev Pathol, 2009, 4:199-227.
|
| [10] |
Resnick KE, Alder H, Hagan JP, et al. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform[J]. Gynecol Oncol, 2009, 112(1):55-59.
|
| [11] |
Moore RG, Brown AK, Miller MC, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass[J]. Gynecol Oncol, 2008, 108(2):402-408.
|
| [12] |
Kan CW, Hahn MA, Gard GB, et al. Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer[J]. BMC Cancer, 2012, 12:627.
|
| [13] |
Guo F, Tian J, Lin Y, et al. Serum microRNA-92 expression in patients with ovarian epithelial carcinoma[J]. J Int Med Res, 2013, 41(5):1456-1461.
|
| [14] |
Xu YZ, Xi QH, Ge WL, et al.Identification of serum microRNA-21 as a biomarker for early detection and prognosis in human epithelial ovarian cancer[J]. Asian Pac J Cancer Prev, 2013, 14(2):1057-1060.
|
| [15] |
Hong F, Li Y, Xu Y, et al. Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer[J]. J Int Med Res, 2013, 41(1):64-71.
|
| [16] |
Zheng H, Zhang L, Zhao Y, et al.Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer[J]. PLoS One, 2013, 8(11):e77853.
|
| [17] |
Langhe R, Norris L, Saadeh FA, et al. A novel serum microRNA panel to discriminate benign from malignant ovarian disease[J]. Cancer Lett, 2015, 356(2 Pt B):628-636.
|
| [18] |
冯朝霞，黄余良，欧阳先辉．卵巢癌患者血浆miRNA水平与顺铂化疗敏感性的相关性研究[J]．中国医师杂志，2014，16(7):930-933.
|
| [19] |
Torres A, Torres K, Pesci A, et al. Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma[J]. BMC Cancer, 2012, 12:369.
|
| [20] |
Torres A, Torres K, Pesci A, et al.Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients[J]. Int J Cancer, 2013, 132(7):1633-1645.
|
| [21] |
Wang L, Chen YJ, Xu K, et al.Circulating microRNAs as a fingerprint for endometrial endometrioid adenocarcinoma[J]. PLoS One, 2014, 9(10):e110767.
|
| [22] |
贾英华．子宫内膜癌患者血清Has-miR-141的表达及其临床意义[D]．北京协和医学院，2013.
|
| [23] |
谭志琴，刘伏香，唐海林，等．子宫内膜癌患者血清hsa-miR-155的表达及其临床意义[J]. 中华妇产科杂志，2010，45(10):772-774.
|
| [24] |
陈玉芬．子宫内膜癌患者血清中miR-155的表达及其临床意义研究[J]．中国医药导刊，2014，16(1):160-161.
|
| [25] |
Yu J, Wang Y, Dong R, et al.Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion[J]. J Cancer Res Clin Oncol, 2012, 138(4):671-674.
|
| [26] |
Juan L, Tong HL, Zhang P, et al.Identification and characterization of novel serum microRNA candidates from deep sequencing in cervical cancer patients[J]. Sci Rep, 2014, 4:6277.
|
| [27] |
Chen J, Yao D, Li Y, et al.Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma[J]. Int J Mol Med, 2013, 32(3):557-567.
|
| [28] |
Zhao S, Yao D, Chen J, et al.Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer[J]. Genet Test Mol Biomarkers, 2013, 17(8):631-636.
|
| [29] |
贺婵娟，姚德生，陈军莹．miR-21在宫颈鳞癌淋巴结转移患者血清中的表达及其临床意义[J]．实用医学杂志，2012，28(19):3195-3197.
|
| [30] |
Ma Q, Wan G, Wang S, et al.Serum microRNA-205 as a novel biomarker for cervical cancer patients[J]. Cancer Cell Int, 2014, 14:81.
|
| [31] |
Keller A, Leidinger P, Bauer A, et al.Toward the blood-borne miRNome of human diseases[J]. Nat Methods, 2011, 8(10):841-843.
|